Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Buy
9,049
+4,395
+94% +$946K 0.06% 176
2026
Q1
$1.01M Sell
4,654
-1,752
-27% -$389K 0.04% 197
2025
Q4
$1.46M Buy
6,406
+2,280
+55% +$519K 0.05% 165
2025
Q3
$955K Buy
4,126
+1,551
+60% +$316K 0.05% 129
2025
Q2
$478K Sell
2,575
-508
-16% -$94.4K 0.03% 157
2025
Q1
$646K Sell
3,083
-66
-2% -$12.8K 0.04% 129
2024
Q4
$560K Buy
3,149
+255
+9% +$46.9K 0.04% 139
2024
Q3
$572K Buy
2,894
+595
+26% +$111K 0.04% 135
2024
Q2
$394K Sell
2,299
-412
-15% -$68.2K 0.03% 130
2024
Q1
$494K Buy
2,711
+50
+2% +$8.62K 0.04% 125
2023
Q4
$412K Buy
2,661
+490
+23% +$71.4K 0.03% 126
2023
Q3
$324K Sell
2,171
-612
-22% -$89.8K 0.03% 133
2023
Q2
$375K Sell
2,783
-209
-7% -$30.6K 0.03% 123
2023
Q1
$477K Buy
+2,992
New +$457K 0.05% 111

Other funds holding ABBV

BIP Wealth's ABBV Position: Q2 2026 in Review

BIP Wealth increased its AbbVie (ABBV) stake by 94% in Q2 2026, buying an estimated $946K and bringing the position to 9,049 shares worth $2.28M. The position accounts for 0.06% of the portfolio, ranked #176.

BIP Wealth first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 2,242 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BIP Wealth held 9,049 shares of AbbVie worth $2.28M as of Q2 2026.
  • BIP Wealth bought 4,395 AbbVie shares in Q2 2026, an estimated $946K.
  • AbbVie made up 0.06% of BIP Wealth's portfolio in Q2 2026, its #176 holding.
  • BIP Wealth first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 2,242 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BIP Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.